Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wilson, SJ
Nutt, DJ
Alford, C
Argyropoulos, SV
Baldwin, DS
Bateson, AN
Britton, TC
Crowe, C
Dijk, D-J
Espie, CA
Gringras, P
Hajak, G
Idzikowski, C
Krystal, AD
Nash, JR
Selsick, H
Sharpley, AL
and
Wade, AG
2010.
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.
Journal of Psychopharmacology,
Vol. 24,
Issue. 11,
p.
1577.
Kim, Seog Ju
Lee, Yu Jin
Kim, Hyunkyung
Cho, In Hee
Lee, Jun-Young
and
Cho, Seong-Jin
2010.
Age as a moderator of the association between depressive symptoms and morningness–eveningness.
Journal of Psychosomatic Research,
Vol. 68,
Issue. 2,
p.
159.
Rahman, Shadab Ataur
Marcu, Shai
Kayumov, Leonid
and
Shapiro, Colin Michael
2010.
Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 260,
Issue. 4,
p.
327.
Sockalingam, Sanjeev
Abbey, Susan E.
Alosaimi, Fahad
and
Novak, Marta
2010.
A Review of Sleep Disturbance in Hepatitis C.
Journal of Clinical Gastroenterology,
Vol. 44,
Issue. 1,
p.
38.
Lyseng-Williamson, Katherine A.
2012.
Melatonin Prolonged Release.
Drugs & Aging,
Vol. 29,
Issue. 11,
p.
911.
Hardeland, Rüdiger
2012.
Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction.
The Scientific World Journal,
Vol. 2012,
Issue. ,
p.
1.
de Rooij, Sophia E.
and
van Munster, Barbara C.
2013.
Melatonin Deficiency Hypothesis in Delirium: A Synthesis of Current Evidence.
Rejuvenation Research,
Vol. 16,
Issue. 4,
p.
273.
Lyseng-Williamson, Katherine A.
2013.
Melatonin prolonged release: a guide to its use in the treatment of insomnia in patients aged ≥55 years.
Drugs & Therapy Perspectives,
Vol. 29,
Issue. 5,
p.
125.
Vijayakumar, HN
Ramya, K
Duggappa, DevikaRani
Veeranna Gowda, KM
Sudheesh, K
Nethra, SS
and
Raghavendra Rao, RS
2016.
Effect of melatonin on duration of delirium in organophosphorus compound poisoning patients: A double-blind randomised placebo controlled trial.
Indian Journal of Anaesthesia,
Vol. 60,
Issue. 11,
p.
814.
Foster, Jennifer
Burry, Lisa D.
Thabane, Lehana
Choong, Karen
Menon, Kusum
Duffett, Mark
Cheung, Alexandra
Guenette, Melanie
Chimunda, Timothy
and
Rose, Louise
2016.
Melatonin and melatonin agonists to prevent and treat delirium in critical illness: a systematic review protocol.
Systematic Reviews,
Vol. 5,
Issue. 1,
Burry, Lisa
Scales, Damon
Williamson, David
Foster, Jennifer
Mehta, Sangeeta
Guenette, Melanie
Fan, Eddy
Detsky, Michael
Azad, Azar
Bernard, Francis
and
Rose, Louise
2017.
Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study.
BMJ Open,
Vol. 7,
Issue. 3,
p.
e015420.
Wilson, Sue
Anderson, Kirstie
Baldwin, David
Dijk, Derk-Jan
Espie, Audrey
Espie, Colin
Gringras, Paul
Krystal, Andrew
Nutt, David
Selsick, Hugh
and
Sharpley, Ann
2019.
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update.
Journal of Psychopharmacology,
Vol. 33,
Issue. 8,
p.
923.
Igwe, Ezinne O.
Nealon, Jessica
Mohammed, Mohammed
Hickey, Blake
Chou, Kuei-Ru
Chen, Kee-Hsin
and
Traynor, Victoria
2020.
Multi-disciplinary and pharmacological interventions to reduce post-operative delirium in elderly patients: A systematic review and meta-analysis.
Journal of Clinical Anesthesia,
Vol. 67,
Issue. ,
p.
110004.